Gilead Sciences (GILD) Short-term Investments (2009 - 2026)

Gilead Sciences (GILD) has 17 years of Short-term Investments data on file, last reported at $15.0 million in Q1 2026.

• Quarterly Short-term Investments changed N/A year-over-year to $15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.0 million (changed N/A YoY) and the FY2025 annual result came in at $68.0 million, changed N/A from the prior year.
• Short-term Investments fell to $15.0 million in Q1 2026, from $68.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $1.2 billion in Q4 2023 to a low of $15.0 million in Q1 2026.
• A 4-year average of $691.2 million and a median of $948.5 million in 2022 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2022 — Short-term Investments plunged 43.38% — and 2023, when it gained 21.17%.
• Tracing GILD's Short-term Investments over 4 years: stood at $973.0 million in 2022, then gained by 21.17% to $1.2 billion in 2023, then slumped by 94.23% to $68.0 million in 2025, then slumped by 77.94% to $15.0 million in 2026.
• The last three Short-term Investments figures came in at $15.0 million (Q1 2026), $68.0 million (Q4 2025), and $19.0 million (Q3 2025), per Business Quant data.